Interferon (IFN)-γ was recently proposed as a treatment for idiopathic pulmonary fibrosis. We
report on four patients who developed acute respiratory failure with new alveolar opacities …

Idiopathic pulmonary fibrosis (IPF) is a disease with progressive and devastating
deterioration of lung function and a fatal prognosis, despite aggressive therapeutic attempts …

Idiopathic pulmonary fibrosis (IPF) is the most common of the interstitial pneumonias of
unknown etiology and the most aggressive interstitial lung disease (1). In this context, it is …

Idiopathic pulmonary fibrosis is a chronic condition of the lung parenchyma involving
progressive injury, inflammation, and fibrosis. Data collected from October 1988 through …

OBJECTIVE To report on observations made in a group of patients with idiopathic
pulmonary fibrosis/usual interstitial pneumonia (IPF/UIP) who were treated with interferon …

Background: The only proven therapeutic option for idiopathic pulmonary fibrosis (IPF) is
lung transplantation. It is biologically plausible that interferon gamma-1b (G-IFN) may halt or …

Background: Prospective data defining the clinical course in idiopathic pulmonary fibrosis
(IPF) are sparse. Objective: To analyze the clinical course of patients with mild to moderate …

Interferon gamma-1b for the treatment of idiopathic pulmonary fibrosis. - Abstract - Europe
PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers …

Idiopathic pulmonary fibrosis (IPF) has no effective treatment and a relatively short life
expectancy after diagnosis. Interferon a (IFNa) inhibits the growth of proliferating fibroblasts …

Background Idiopathic pulmonary fibrosis is a progressive, fatal disease with no known
efficacious therapy. Methods In a double-blind, multinational trial, we randomly assigned …